Titre:
  • Disease-free survival as a surrogate for overall survival in patients with HER2-positive, early breast cancer in trials of adjuvant trastuzumab for up to 1 year: a systematic review and meta-analysis
Auteur:Saad, Everardo Delforge; Squifflet, Pierre; Burzykowski, Tomasz; Quinaux, Emmanuel; Delaloge, Suzette; Mavroudis, Dimitris; Perez, Edith A; Piccart-Gebhart, Martine; Schneider, Bryan B.P.; Slamon, Dennis; Wolmark, Norman; Buyse, Marc
Informations sur la publication:Lancet oncology, 20, 3, page (361-370)
Statut de publication:Publié, 2019-03
Sujet CREF:Cancérologie
Note générale:SCOPUS: ar.j
Langue:Anglais
Identificateurs:urn:issn:1470-2045
info:doi/10.1016/S1470-2045(18)30750-2
info:pii/S1470204518307502
info:scp/85062172145
info:pmid/30709633